Member Info for lordloadsoflolly

Ezhik - I think you’ll find Bo DID confirm that in an investor interview.

Rather than speculating, one to ask on 28th if anyone’s doubtful still.

Ok - thanks for correcting.

Notwithstanding that, the options strongly incentivise SOH to create shareholder value. Albeit they have a 10 year shelf life from the issue date.

Aspex - whatever the motive, that was some commitment financially.

From which presumably SOH fully intended & believed he’d make a decent return eventually.

Question, I guess, is was he right - and if so, how long is eventually?

Thanks, but not sure we need a running price commentary.

FS - you may be right. But I say let’s wait until the end of H1.

Seems illogical to hold onto any share you’ve totally lost faith in, simply because it’s already lost so much of its value. But hey ho.

FS - bizarre you still hold 300,000 shares in Opti (as of your 6th May post), yet haven’t had a decent word to say about them in months.

You told us last week it was in case some positive Sweetbiotix news emerged. But one week on you seem pretty certain it won’t.

Sau - don’t worry, I’ve taken it with a container load of salt.

FS - I see Sweet’s partnerships potentially being direct with major food/drink manufacturers who would already have more than enough funds & marketing nous.

FS - care to explain the last line of your most recent post?

Johncut - I agree with you about the gold price.

Whilst it may come off this year’s highs, it’s likely to remain high as long as current world “leaders” are in place.

Meconopsis - fair point. Except there’s many a slip ‘twixt cup & lip.

Until any of those IPOs actually happens and their value is known, a discount will persist to reflect the ongoing risk.

Alessandro - “The point is how much pricing power IQE does have with them.”

Historically, despite it allegedly being “the leading supplier”, IQE has enjoyed little pricing power with Macom or any of its other customers. Which is why the reported gross margin has always been so poor. Your suggestion of a 20% GM won’t cut it by a long way. Needs to be at least double that, given all the massive fixed costs.

Joed - won’t keep replying as it risks getting boring for everyone else now!

But the way I see it, the current 4-5% premium to NAV reflects a potential upwards re-rate in the value of SMT’s SpaceX holding. As I said before, SMT has historically traded at a 5-22% discount to NAV.

So, in effect, an uplift of anywhere between 9% & 27% is already priced in.

I disagree with your point that SMT shouldn’t be issuing shares from Treasury at current price levels. Less than 2.5 years ago, SMT was heavily buying back shares to Treasury when the price stood well below £7. Fine by me for them now to bank a more than doubling in price & remove a small element of risk. Shares don’t go up for ever, particularly when they’re invested in sectors which have already appreciated significantly.

Perhaps IQE should look at Macom’s gross margin, then ask itself why it hasn’t increased its price to them.

Or if it has, why it doesn’t do so more.

Yesterday’s TU means that even with the recent SP rise, at the lower end of revised FY profit guidance, RFX is on a P/E of just 5.

Surely that’s way too low. Unless investors think the windfall from current gold price spikes is temporary. Which it may well prove to be. Even so, this looks undervalued to me.

Letitrun - agreed. I get why FS has a jaundiced take on Opti. After all, SOH has history for overpromising.

But then in the same breath to suggest Skin’s problems are largely behind it and that it might rise phoenix-like once suspension’s lifted strikes me as ingenuous to say the least. Generally, suspension is employed to maintain some sort of stability when bad news hits that would otherwise cause a company’s SP to implode. Not when the sunny uplands are beckoning and a sustainable upwards rerate is imminent.

FS - it’s not a huge leap to assume SOH would keep half an ear open about SBTX, given his heavy involvement in its development.

That wouldn’t make any share sale illegal or an insider trade. Any more than any other Director’s trades in a company they work for.

Management - past & present - is always likely to know more about a company than a rank outsider.

*postcard!

FS - as was previously said, boils down to who's more likely to have the inside track on SBTX.

SOH or some private investor with deep pockets.

Answers on a postcode please. From SBTX's latest RNS, sounds like we'll know either way before the month's out.